Iaboni et al. demonstrated that GL21.T-conjugated miR-212 enhances sensitization to TNF-related apoptosis-inducing ligand (TRAIL) in human non-small cell lung cancer cells [200]. The gene discussed is TNFSF10; the disease is non-small cell lung carcinoma.